News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,671 Results
Type
Article (4974)
Company Profile (22)
Press Release (215675)
Section
Business (82186)
Career Advice (460)
Deals (15038)
Drug Delivery (8)
Drug Development (19053)
Employer Resources (30)
FDA (3674)
Job Trends (3894)
News (120078)
Policy (7497)
Tag
Academia (290)
Alliances (14691)
Alzheimer's disease (213)
Approvals (3668)
Bankruptcy (94)
Best Places to Work (2829)
Biotechnology (24)
Breast cancer (21)
Cancer (201)
Career advice (391)
Cell therapy (44)
Clinical research (15594)
Collaboration (68)
Compensation (58)
COVID-19 (292)
C-suite (31)
Data (216)
Diagnostics (1988)
Earnings (39576)
Employer resources (31)
Events (36773)
Executive appointments (106)
FDA (3766)
Funding (67)
Gene therapy (22)
GLP-1 (94)
Government (404)
Healthcare (4995)
Infectious disease (301)
Inflammatory bowel disease (21)
Interviews (53)
IPO (7725)
Job creations (1119)
Job search strategy (360)
Layoffs (95)
Legal (2321)
Lung cancer (23)
Manufacturing (24)
Medical device (3811)
Medtech (3812)
Mergers & acquisitions (7332)
Metabolic disorders (56)
Neuroscience (250)
NextGen Class of 2024 (1671)
Non-profit (722)
Northern California (420)
Obesity (31)
Opinion (28)
People (24095)
Phase I (4639)
Phase II (6774)
Phase III (5387)
Pipeline (105)
Postmarket research (625)
Preclinical (1820)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (30)
Real estate (1868)
Regulatory (4968)
Research institute (298)
Resumes & cover letters (68)
Southern California (308)
Startups (1005)
United States (3509)
Vaccines (24)
Date
Today (54)
Last 7 days (266)
Last 30 days (795)
Last 365 days (11243)
2024 (9452)
2023 (13194)
2022 (18668)
2021 (19687)
2020 (18247)
2019 (13213)
2018 (10207)
2017 (10008)
2016 (9161)
2015 (12119)
2014 (9588)
2013 (7711)
2012 (8335)
2011 (8796)
2010 (8636)
Location
Africa (184)
Arizona (47)
Asia (11263)
Australia (1548)
California (841)
Canada (407)
China (24)
Colorado (32)
Connecticut (43)
Europe (23875)
Florida (110)
Georgia (18)
Idaho (23)
Illinois (69)
Indiana (33)
Japan (23)
Kansas (23)
Maine (32)
Maryland (114)
Massachusetts (729)
Michigan (55)
Minnesota (95)
Montana (16)
New Jersey (282)
New York (260)
North Carolina (224)
Northern California (420)
Ohio (32)
Pennsylvania (185)
South America (273)
Southern California (308)
Texas (97)
Utah (24)
Washington State (84)
220,671 Results for "sysmex corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States
Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.
April 2, 2024
·
2 min read
Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay
Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies.
December 14, 2023
·
3 min read
Business
Sysmex America Announces Dan Zortman as New CEO
July 10, 2024
·
2 min read
Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization partnership for Sysmex’s Automated Immunoassay System HISCL™-Series to include the field of neurodegenerative diseases, following the discussion based on the Basic Agreement on Business Collaboration in the field of immunoassay signed in October 2023*.
November 30, 2023
·
3 min read
Drug Development
Sysmex Inostics’ RAS-RAF-SEQ Assay Receives New York State Department of Health CLEP Approval for Use in Clinical Trials
September 17, 2024
·
3 min read
BioMidwest
Sysmex America Becomes Exclusive Distributor of vermicon VIT® System in Canada, Latin America and Americas
Sysmex America, Inc., a leading diagnostic solutions company, has been named the exclusive distributor of vermicon identification technology System in Canada, Latin America and all the Americas.
December 14, 2023
·
2 min read
Job Trends
Roche expands long-term alliance with Sysmex
Roche announced the expansion of their Global Business Partnership Agreement with Sysmex.
August 3, 2023
·
4 min read
BioCapital
Sysmex Inostics Opens Cancer Research Excellence Program for Submissions
Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, has opened submissions for its Cancer Research Excellence Program (CREP).
February 14, 2023
·
4 min read
BioCapital
Sysmex Inostics Exhibits at American Association for Cancer Research Annual Meeting 2023 in Orlando
Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm and CLIA-certified lab, is exhibiting at the American Association for Cancer Research® (AACR) Annual Meeting 2023 in Orlando, FL from April 16, 2023, through April 19, 2023.
April 17, 2023
·
4 min read
Business
Juntendo University, Sysmex, and ThinkCyte Collaborate to Advance the Early Detection and Treatment of Blood Cancer
Juntendo University, Sysmex Corporation, and ThinkCyte K.K. have announced a collaborative research partnership to advance the early detection and treatment of chronic myelogenous leukemia (CML).
April 18, 2023
·
5 min read
1 of 22,068
Next